Hemedex, Inc.


Hemedex, Inc., was founded in 2000 to commercialize a proprietary platform technology conceived at the Massachusetts Institute of Technology (MIT) to quantify tissue perfusion (i.e., blood flow at the capillary level).

This technology addresses the need for real-time, prognostic data in complex medical and surgical procedures.


222 Third Street, Suite 0123
Cambridge, Massachusetts 02142
United States

Get Directions

Upgrade Your Listing